Growth hormone treatment in the United States: Demographic and diagnostic features of 2331 children
Open accessThe DOI matches its Crossref record.
Abstract
Demographic, diagnostic, and baseline clinical data were collected for a large cohort (N = 2331) of children who started treatment with biosynthetic human growth hormone (GH) between October 1985 and October 1987. Eighty-one percent met classic criteria for GH deficiency and were classified as having idiopathic GH deficiency (59%), organic GH deficiency (18%), or septo-optic dysplasia (4%). The remaining 19.8% had short stature of varied causes. Height standard deviation score at diagnosis, maximum GH response to stimulation, and heights of parents were examined according to gender, race, age at diagnosis, and previous treatment history. The predominance of boys in all subgroups except septooptic dysplasia, and the observation that girls with idiopathic GH deficiency were comparatively shorter than boys at diagnosis, suggest ascertainment bias. Black children with idiopathic GH deficiency were shorter than white children at diagnosis, and their low overall representation (6.0%) compared with their percentage in the at-risk population (12.9%) also suggest ascertainment bias among races. These data provide a profile of GH deficiency as it is currently defined and expose possible inherent biases in the diagnostic process. Now that GH supply is no longer limited, criteria for its use should be formulated to avoid apparent underascertainment or late diagnosis of GH deficiency in girls and black children.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The Diagnosis of Growth Hormone Deficiency in Children and Adults
Shalet, S. M., Toogood, A., Rahim, A., & Brennan, B. M. D. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.2.0329 · Cited by 414
Diagnostic controversy: the diagnosis of childhood growth hormone deficiency revisited
Rosenfeld, R. G. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.5.1532 · Cited by 372
Self-citationLong-term safety of recombinant human growth hormone in children
Bell, J., Parker, K. L., Swinford, R. D., Hoffman, A. R., Maneatis, T., & Lippe, B. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0178 · Cited by 301
“Long-Term GH Safety in Children J Clin Endocrinol Metab, January 2010, 95(1):167–177”
BackgroundInfluentialSelf-citationTreatment of Glucocorticoid-Induced Growth Suppression with Growth Hormone
Allen, D. B., Julius, J. R., Breen, T. J., & Attie, K. M. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.8.5036 · Cited by 153
“35 mg/kgzday) (2) appeared to interfere with GH responsiveness.”
Background
Metadata
- Authors
- August, G. P., Lippe, B. M., Blethen, S. L., Rosenfeld, R. G., Seelig, S. A., Johanson, A. J., Compton, P. G., Frane, J. W., McClellan, B. H., & Sherman, B. M.
- Venue
- The Journal of Pediatrics
- Publisher
- Elsevier BV
- Published
- 1990-06
- Volume
- 116
- Issue
- 6
- Pages
- 899-903
- ISSN
- 0022-3476 (ISSN-L)
- OpenAlex
- W2079710799
- Cited by
- 104
- References
- 0
- FWCI
- 1.19
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Growth hormone treatment in the United States: Demographic and diagnostic features of 2331 children. https://app.cochat.ai/papers/10.1016/s0022-3476(05)80647-x
- The paper
- August, G. P., Lippe, B. M., Blethen, S. L., Rosenfeld, R. G., Seelig, S. A., Johanson, A. J., Compton, P. G., Frane, J. W., McClellan, B. H., & Sherman, B. M. (1990). Growth hormone treatment in the United States: Demographic and diagnostic features of 2331 children. The Journal of Pediatrics. https://doi.org/10.1016/s0022-3476(05)80647-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.